Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Badger Meter
BMI
$3.87B
| $974K | ﹤0.01% |
26,500
+13,200
| +99% | +$486K |
|
|
LADR
2552
Ladder Capital
LADR
$1.26B
| $972K | ﹤0.01% |
67,330
-13,529
| -17% | -$191K |
|
2553
Curis
CRIS
$4.1M
| $969K | ﹤0.01% |
174
-7
| -4% | -$38.9K |
|
2554
Radiant Logistics
RLGT
$402M
| $968K | ﹤0.01% |
193,600
+152,700
| +373% | +$703K |
|
|
STZ.B
2555
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $959K | ﹤0.01% |
5,900
+300
| +5% | +$46.4K |
|
|
MSBF
2556
DELISTED
MSB Financial Corp.
MSBF
| $957K | ﹤0.01% |
58,000
+166
| +0.3% | +$2.57K |
|
|
APTI
2557
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $954K | ﹤0.01% |
+81,331
| New | +$1.18M |
|
2558
Xencor
XNCR
$1.71B
| $949K | ﹤0.01% |
+39,672
| New | +$956K |
|
2559
Stryker
SYK
$132B
| $948K | ﹤0.01% |
+7,200
| New | +$910K |
|
|
GLA
2560
DELISTED
GlassBridge Enterprises, Inc.
GLA
| $948K | ﹤0.01% |
+196,700
| New | +$1.25M |
|
2561
BlueLinx
BXC
$692M
| $946K | ﹤0.01% |
103,960
+44,800
| +76% | +$322K |
|
|
ENG
2562
DELISTED
ENGlobal Corp
ENG
| $942K | ﹤0.01% |
63,665
+11,461
| +22% | +$216K |
|
|
BHR
2563
Braemar Hotels & Resorts
BHR
$140M
| $941K | ﹤0.01% |
89,611
-59,380
| -40% | -$738K |
|
|
CCM
2564
Concord Medical Services
CCM
$20.5M
| $940K | ﹤0.01% |
19,910
+6,460
| +48% | +$303K |
|
2565
World Acceptance Corp
WRLD
$882M
| $937K | ﹤0.01% |
18,100
-48,300
| -73% | -$2.59M |
|
|
FRTX
2566
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $932K | ﹤0.01% |
1,321
+75
| +6% | +$52.9K |
|
|
CAI
2567
DELISTED
CAI International, Inc.
CAI
| $927K | ﹤0.01% |
+58,900
| New | +$857K |
|
|
RSO
2568
DELISTED
Resource Capital Corp.
RSO
| $920K | ﹤0.01% |
+94,186
| New | +$817K |
|
|
ACRE
2569
Ares Commercial Real Estate
ACRE
$263M
| $914K | ﹤0.01% |
68,300
-12,637
| -16% | -$170K |
|
2570
Minerals Technologies
MTX
$2.25B
| $912K | ﹤0.01% |
+11,900
| New | +$922K |
|
2571
Navigator Holdings
NVGS
$1.28B
| $910K | ﹤0.01% |
66,200
+13,600
| +26% | +$161K |
|
2572
Enel Chile
ENIC
$6.11B
| $909K | ﹤0.01% |
+165,200
| New | +$825K |
|
|
BEBE
2573
DELISTED
Bebe Stores Inc
BEBE
| $907K | ﹤0.01% |
230,830
+13,400
| +6% | +$72.5K |
|
2574
CVD Equipment Corp
CVV
$50M
| $904K | ﹤0.01% |
87,100
+7,000
| +9% | +$69.7K |
|
|
BRT
2575
BRT Apartments
BRT
$268M
| $900K | ﹤0.01% |
108,260
+3,700
| +4% | +$31.1K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.